MDI
Umeclidinium / Vilanterol
Anoro Ellipta
- Mechanism of Action
- Contains a long acting muscarinic agent (LAMA) as well as a long-acting beta 2 agonist (LABA), both of which are bronchodilators.
Clinical Use
- Indication
- Maintenance therapy for COPD.
- Adverse Effects
- Tremor
- Palpitations
- Headache
- Dry Mouth
Want more info like this?
- Your electronic clinical medicine handbook
- Guides to help pass your exams
- Tools every medical student needs
- Quick diagrams to have the answers, fast
- Quizzes to test your knowledge
Explore